Morgan Stanley analyst Megan Alexander Clapp downgraded Vital Farms (VITL) to Equal Weight from Overweight with a price target of $24, down from $45. The firm says the company’s lower implied Q1 revenue outlook along with “elevated” industry promotional intensity reduce Vital ‘s near-term visibility and raise questions around the achievability of its fiscal 2026 growth expectations. Morgan Stanley adds the stock’s valuation “appears low.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
